147 related articles for article (PubMed ID: 15801493)
1. Prospective study of plasma enterolactone and prostate cancer risk (Sweden).
Stattin P; Bylund A; Biessy C; Kaaks R; Hallmans G; Adlercreutz H
Cancer Causes Control; 2004 Dec; 15(10):1095-102. PubMed ID: 15801493
[TBL] [Abstract][Full Text] [Related]
2. Circulating enterolactone and prostate cancer risk: a Nordic nested case-control study.
Stattin P; Adlercreutz H; Tenkanen L; Jellum E; Lumme S; Hallmans G; Harvei S; Teppo L; Stumpf K; Luostarinen T; Lehtinen M; Dillner J; Hakama M
Int J Cancer; 2002 May; 99(1):124-9. PubMed ID: 11948503
[TBL] [Abstract][Full Text] [Related]
3. Serum enterolactone concentration is not associated with prostate cancer risk in a nested case-control study.
Kilkkinen A; Virtamo J; Virtanen MJ; Adlercreutz H; Albanes D; Pietinen P
Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1209-12. PubMed ID: 14652283
[TBL] [Abstract][Full Text] [Related]
4. Dietary phytoestrogen, serum enterolactone and risk of prostate cancer: the cancer prostate Sweden study (Sweden).
Hedelin M; Klint A; Chang ET; Bellocco R; Johansson JE; Andersson SO; Heinonen SM; Adlercreutz H; Adami HO; Grönberg H; Bälter KA
Cancer Causes Control; 2006 Mar; 17(2):169-80. PubMed ID: 16425095
[TBL] [Abstract][Full Text] [Related]
5. Plasma enterolactone and risk of prostate cancer in middle-aged Swedish men.
Wallström P; Drake I; Sonestedt E; Gullberg B; Bjartell A; Olsson H; Adlercreutz H; Tikkanen MJ; Wirfält E
Eur J Nutr; 2018 Oct; 57(7):2595-2606. PubMed ID: 28884432
[TBL] [Abstract][Full Text] [Related]
6. Serum enterolactone concentration is not associated with breast cancer risk in a nested case-control study.
Kilkkinen A; Virtamo J; Vartiainen E; Sankila R; Virtanen MJ; Adlercreutz H; Pietinen P
Int J Cancer; 2004 Jan; 108(2):277-80. PubMed ID: 14639615
[TBL] [Abstract][Full Text] [Related]
7. Risk of acute coronary events according to serum concentrations of enterolactone: a prospective population-based case-control study.
Vanharanta M; Voutilainen S; Lakka TA; van der Lee M; Adlercreutz H; Salonen JT
Lancet; 1999 Dec 18-25; 354(9196):2112-5. PubMed ID: 10609816
[TBL] [Abstract][Full Text] [Related]
8. Plasma enterolactone and incidence of endometrial cancer in a case-cohort study of Danish women.
Aarestrup J; Kyrø C; Knudsen KE; Weiderpass E; Christensen J; Kristensen M; Würtz AM; Johnsen NF; Overvad K; Tjønneland A; Olsen A
Br J Nutr; 2013 Jun; 109(12):2269-75. PubMed ID: 23114205
[TBL] [Abstract][Full Text] [Related]
9. Pre-diagnostic plasma enterolactone concentrations and breast cancer prognosis among postmenopausal women - The Danish Diet, Cancer and Health cohort.
Kyrø C; Hansen L; Frederiksen K; Nørskov NP; Bach Knudsen KE; Eriksen AK; Holm M; Tjønneland A; Olsen A
Clin Nutr; 2018 Dec; 37(6 Pt A):2217-2225. PubMed ID: 29154112
[TBL] [Abstract][Full Text] [Related]
10. Prediagnostic enterolactone concentrations and mortality among Danish men diagnosed with prostate cancer.
Eriksen AK; Kyrø C; Nørskov N; Bolvig AK; Christensen J; Tjønneland A; Overvad K; Landberg R; Olsen A
Eur J Clin Nutr; 2017 Oct; 71(10):1235-1240. PubMed ID: 28378849
[TBL] [Abstract][Full Text] [Related]
11. Plasma enterolactone and genistein and the risk of premenopausal breast cancer.
Piller R; Chang-Claude J; Linseisen J
Eur J Cancer Prev; 2006 Jun; 15(3):225-32. PubMed ID: 16679865
[TBL] [Abstract][Full Text] [Related]
12. Plasma enterolactone and breast cancer incidence by estrogen receptor status.
Olsen A; Knudsen KE; Thomsen BL; Loft S; Stripp C; Overvad K; Møller S; Tjønneland A
Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2084-9. PubMed ID: 15598765
[TBL] [Abstract][Full Text] [Related]
13. Circulating enterolactone and risk of endometrial cancer.
Zeleniuch-Jacquotte A; Lundin E; Micheli A; Koenig KL; Lenner P; Muti P; Shore RE; Johansson I; Krogh V; Lukanova A; Stattin P; Afanasyeva Y; Rinaldi S; Arslan AA; Kaaks R; Berrino F; Hallmans G; Toniolo P; Adlercreutz H
Int J Cancer; 2006 Nov; 119(10):2376-81. PubMed ID: 16929490
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms in the CYP19 gene may affect the positive correlations between serum and urine phytoestrogen metabolites and plasma androgen concentrations in men.
Low YL; Taylor JI; Grace PB; Dowsett M; Folkerd E; Doody D; Dunning AM; Scollen S; Mulligan AA; Welch AA; Luben RN; Khaw KT; Day NE; Wareham NJ; Bingham SA
J Nutr; 2005 Nov; 135(11):2680-6. PubMed ID: 16251630
[TBL] [Abstract][Full Text] [Related]
15. Determinants of serum enterolactone concentration.
Kilkkinen A; Stumpf K; Pietinen P; Valsta LM; Tapanainen H; Adlercreutz H
Am J Clin Nutr; 2001 Jun; 73(6):1094-100. PubMed ID: 11382665
[TBL] [Abstract][Full Text] [Related]
16. Plasma enterolactone and risk of colon and rectal cancer in a case-cohort study of Danish men and women.
Johnsen NF; Olsen A; Thomsen BL; Christensen J; Egeberg R; Bach Knudsen KE; Loft S; Overvad K; Tjønneland A
Cancer Causes Control; 2010 Jan; 21(1):153-62. PubMed ID: 19844797
[TBL] [Abstract][Full Text] [Related]
17. Phyto-oestrogens and risk of prostate cancer in Scottish men.
Heald CL; Ritchie MR; Bolton-Smith C; Morton MS; Alexander FE
Br J Nutr; 2007 Aug; 98(2):388-96. PubMed ID: 17403269
[TBL] [Abstract][Full Text] [Related]
18. The Association between Plasma Concentration of Phytoestrogens and Hypertension within the Korean Multicenter Cancer Cohort.
Lee J; Kang JY; Ko KP; Park SK
Nutrients; 2021 Dec; 13(12):. PubMed ID: 34959918
[TBL] [Abstract][Full Text] [Related]
19. Plasma levels of enterolactone and percentage mammographic density among postmenopausal women.
Stuedal A; Gram IT; Bremnes Y; Adlercreutz H; Veierød MB; Ursin G
Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2154-9. PubMed ID: 16172225
[TBL] [Abstract][Full Text] [Related]
20. An incident case-referent study on plasma enterolactone and breast cancer risk.
Hultén K; Winkvist A; Lenner P; Johansson R; Adlercreutz H; Hallmans G
Eur J Nutr; 2002 Aug; 41(4):168-76. PubMed ID: 12242585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
